Lenalidomide in renal insufficiency – balancing the risks and benefits

per Borrello, Ivan
Publicat 2008

Can we change the disease biology of multiple myeloma?

per Borrello, Ivan
Publicat 2012

The Immune Microenvironment of Myeloma

per Noonan, Kimberly, Borrello, Ivan
Publicat 2011

Marrow-Infiltrating Lymphocytes – Role in Biology and Cancer Therapy

per Borrello, Ivan, Noonan, Kimberly A.
Publicat a Front Immunol (2016)

BCMA CAR T cells: the winding path to success

per Borrello, Ivan, Imus, Philip H.
Publicat a J Clin Invest (2019)

Autologous stem cell transplantation and multiple myeloma cancer stem cells

per Matsui, William, Borrello, Ivan, Mitsiades, Constantine
Publicat 2012

Myeloid derived suppressor cells promote cross-tolerance in B cell lymphoma by expanding regulatory T cells

per Serafini, Paolo, Mgebroff, Stephanie, Noonan, Kimberly, Borrello, Ivan
Publicat 2008

Bortezomib and thalidomide, a steroid free regimen in newly diagnosed patients with multiple myeloma

per Ghosh, Nilanjan, Ye, Xiaobu, Ferguson, Anna, Huff, Carol Ann, Borrello, Ivan
Publicat 2011

Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy

per Chaudhry, Vinay, Cornblath, David R., Polydefkis, Michael, Ferguson, Anna, Borrello, Ivan
Publicat 2008

Identification of differences in immunotherapy knowledge and practice patterns among oncologists from six European countries

per BORRELLO, IVAN MARQUES, SCHAFFER, MADELINE MAG, ROEHRL, ELENA, MARSHALL, JESSICA FALCO
Publicat 2014

Targeting Immune Suppression with PDE-5 Inhibition in End-Stage Multiple Myeloma

per Noonan, Kimberly A., Ghosh, Nilanjan, Rudraraju, Lakshmi, Bui, Marilyn, Borrello, Ivan
Publicat 2014

Development of target-specific treatments in multiple myeloma

per Chanan-Khan, Asher A., Borrello, Ivan, Lee, Kelvin P., Reece, Donna E.
Publicat 2010

Total cost comparison in relapsed/refractory multiple myeloma

per Durie, Brian, Binder, Gary, Pashos, Chris, Khan, Zeba, Hussein, Mohamad, Borrello, Ivan
Publicat 2013

In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance

per Sotomayor, Eduardo M., Borrello, Ivan, Tubb, Erev, Allison, James P., Levitsky, Hyam I.
Publicat 1999

A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma

per Noonan, Kimberly, Marchionni, Luigi, Anderson, Judy, Pardoll, Drew, Roodman, G. David, Borrello, Ivan
Publicat 2010

Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma

per Ghosh, Nilanjan, Tucker, Noah, Zahurak, Marianna, Wozney, Jocelyn, Borrello, Ivan, Huff, Carol Ann
Publicat a Am J Hematol (2014)

Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation

per Mirmonsef, Paria, Tan, Gladys, Zhou, Gang, Morino, Tricia, Noonan, Kimberly, Borrello, Ivan, Levitsky, Hyam I.
Publicat 2008

Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses

per Noonan, Kimberly, Rudraraju, Lakshmi, Ferguson, Anna, Emerling, Amy, Pasetti, Marcela F., Huff, Carol A., Borrello, Ivan
Publicat 2012

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

per Staveley-O’Carroll, Kevin, Sotomayor, Eduardo, Montgomery, Jami, Borrello, Ivan, Hwang, Leon, Fein, Steve, Pardoll, Drew, Levitsky, Hyam
Publicat 1998

In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity

per Horna, Pedro, Cuenca, Alex, Cheng, Fengdong, Brayer, Jason, Wang, Hong-Wei, Borrello, Ivan, Levitsky, Hyam, Sotomayor, Eduardo M.
Publicat 2006